Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04518241 · ClinicalTrials.gov registry record · NA
Supporting Health Behavior Among Persons Living With HIV Using Tech, MOST, and Behavioral Economics
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT04518241 is a NA study that has completed, run by New York University. The registered enrollment target is 80 participants.
The verdict
NCT04518241, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The present study focuses on adult persons living with HIV in the New York City and Newark, New Jersey metropolitan areas who are not highly adherent to HIV medication and who do not evidence undetectable HIV viral load (the ultimate goal of HIV treatment). Those who have not decided whether they wish to take HIV medications are invited to enroll. The study uses technology, is grounded in principles of behavioral economics, and uses the multiphase optimization strategy (MOST) to examine the acceptability, feasibility, and evidence of efficacy of three intervention components. The components are intended to increase rates of HIV viral suppression in the sample. The three components are: prizes for viral suppression (fixed compensation \[$275\] or lottery prizes \[up to $500\]), text messages and quiz questions that generate points to earn prizes (to foster engagement), and counseling sessions grounded in the motivational interviewing approach to help participants articulate goals with respect to health and viral suppression, identify and resolve barriers to HIV medication use, and build motivation for viral suppression. Participants are assessed at baseline and then 5- and 8-months later.
Interventions
- BEHAVIORAL MI sessions
- BEHAVIORAL TMQQ
- BEHAVIORAL Type of compensation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2022-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04518241
The ClinicalTrials.gov registry entry for NCT04518241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MI sessions is the first listed.
NCT04518241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04518241 about?
NCT04518241 is a clinical study titled "Supporting Health Behavior Among Persons Living With HIV Using Tech, MOST, and Behavioral Economics". The present study focuses on adult persons living with HIV in the New York City and Newark, New Jersey metropolitan areas who are not highly adherent to HIV medication and who do not evidence undetectable HIV viral load (the ultimate goal of HIV treatment). Those who have not decided whether they wi...
What is the current status of trial NCT04518241?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2020-08-14. Estimated completion is 2022-07-15.
What interventions are being tested in trial NCT04518241?
The interventions under investigation include: MI sessions (BEHAVIORAL), TMQQ (BEHAVIORAL), Type of compensation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04518241?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.